These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 21596488

  • 1. Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer.
    Chen PC, Chen YC, Lai LC, Tsai MH, Chen SK, Yang PW, Lee YC, Hsiao CK, Lee JM, Chuang EY.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1996-2003. PubMed ID: 21596488
    [Abstract] [Full Text] [Related]

  • 2. Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
    Lee JM, Yang SY, Yang PW, Shun CT, Wu MT, Hsu CH, Lin CC, Cheng JC, Wang YH, Chuang TH, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC.
    Ann Surg Oncol; 2011 Jul 01; 18(7):2066-73. PubMed ID: 21298351
    [Abstract] [Full Text] [Related]

  • 3. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation.
    Hatakenaka M, Yonezawa M, Nonoshita T, Nakamura K, Yabuuchi H, Shioyama Y, Nagao M, Matsuo Y, Kamitani T, Higo T, Nishikawa K, Setoguchi T, Honda H.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e67-73. PubMed ID: 22365626
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e593-9. PubMed ID: 21658851
    [Abstract] [Full Text] [Related]

  • 6. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.
    Anticancer Res; 1999 Nov 15; 19(5C):4463-7. PubMed ID: 10650793
    [Abstract] [Full Text] [Related]

  • 7. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):442-8. PubMed ID: 19307067
    [Abstract] [Full Text] [Related]

  • 10. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.
    Lamas MJ, Duran G, Gomez A, Balboa E, Anido U, Bernardez B, Rana-Diez P, Lopez R, Carracedo A, Barros F.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):138-44. PubMed ID: 21167658
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H, Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG).
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):684-90. PubMed ID: 20932658
    [Abstract] [Full Text] [Related]

  • 12. [Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer].
    Shibata S, Kawasaki H, Nakai M, Morohashi H, Matsuya H, Yamada K, Morita T, Sasaki M.
    Gan To Kagaku Ryoho; 2002 Nov 01; 29(12):2209-12. PubMed ID: 12484039
    [Abstract] [Full Text] [Related]

  • 13. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer.
    Abou-Jawde RM, Mekhail T, Adelstein DJ, Rybicki LA, Mazzone PJ, Caroll MA, Rice TW.
    Chest; 2005 Jul 01; 128(1):250-5. PubMed ID: 16002943
    [Abstract] [Full Text] [Related]

  • 14. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 15. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H.
    J Surg Oncol; 2005 Jun 15; 90(4):209-19. PubMed ID: 15906363
    [Abstract] [Full Text] [Related]

  • 16. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
    Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG.
    Cancer; 2006 Sep 01; 107(5):967-74. PubMed ID: 16874819
    [Abstract] [Full Text] [Related]

  • 17. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.
    Posner MC, Gooding WE, Landreneau RJ, Rosenstein MM, Clarke MR, Peterson MS, Lembersky BC.
    Cancer J Sci Am; 1998 Sep 01; 4(4):237-46. PubMed ID: 9689982
    [Abstract] [Full Text] [Related]

  • 18. Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols.
    Li CY, Huang PM, Chu PY, Chen PM, Lin MW, Kuo SW, Lee JM.
    Biomed Res Int; 2016 Sep 01; 2016():6423297. PubMed ID: 27777949
    [Abstract] [Full Text] [Related]

  • 19. [A case of stage IV (N4) esophageal cancer successfully treated with concurrent chemoradiotherapy].
    Tsuchiyama T, Maeda H, Iida A, Fujita T, Kobayashi T, Katayama SK, Hirose K, Yamaguch A, Nakagawara G.
    Gan To Kagaku Ryoho; 1998 Oct 01; 25(12):1965-8. PubMed ID: 9797821
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):397-404. PubMed ID: 17097833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.